Status:
COMPLETED
Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis
Lead Sponsor:
Amgen
Conditions:
Postmenopausal Osteoporosis
Eligibility:
FEMALE
Up to 90 years
Phase:
PHASE3
Brief Summary
This study will determine whether treatment with AMG 162 can prevent lumbar spine bone loss in both early and late postmenopausal women with osteopenia, and to further test the safety and tolerability...
Eligibility Criteria
Inclusion
- Eligibility Criteria
- \- Postmenopausal women with Osteopenia (lumbar spine bone mineral density T-score between 1.0 and -2.5)
Exclusion
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
332 Patients enrolled
Trial Details
Trial ID
NCT00091793
Start Date
August 1 2004
End Date
March 1 2009
Last Update
December 31 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.